Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Master Protocol for Biomarker-Based Treatment of AML (The Beat AML Trial)

NCT03013998 is registered in ClinicalTrials.gov with Beat AML, LLC as lead sponsor.

NCT NCT03013998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03013998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Master Protocol for Biomarker-Based Treatment of AML (The Beat AML Trial)
Lead sponsor
Beat AML, LLC
Phase
Phase 2/3
Overall status
Recruiting
Start date
November 30, 2016
Completion date
December 31, 2032
Enrollment
3,000 (estimated)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

previously untreated relapsed refractory acute myeloid leukemia